Original article Efficacy tolerability bowel preparations diabetic patients randomized controlled trial Authors Mohammad F Madhoun1 2 Khadija K Chaudrey1 2 Sian S Chisholm1 2 Aftab Ahmed1 2 Belinda Frost1 William M Tierney1 2 Institutions 1 Veterans Affairs Medical Center Oklahoma City Oklahoma United States 2 Division Digestive Diseases Nutrition Department Internal Medicine University Oklahoma Health Sciences Center Oklahoma City Oklahoma United States submitted 2582017 accepted revision 822018 Bibliography DOI httpsdoiorg101055a06503908 Endoscopy International Open 2018 06 E1157E1163 Georg Thieme Verlag KG Stuttgart New York ISSN 23643722 Corresponding author Mohammad F Madhoun MD MS Director Endoscopy Veterans Affairs Medical Center Associate Professor Medicine University Oklahoma Health Sciences Center Division Digestive Diseases Nutrition Andrews Academic Tower Suite 7400 800 Stanton L Young Blvd Oklahoma City OK 73104 Fax 14052715803 mohammadmadhounouhscedu ABSTR AC T Background study aims Diabetes mellitus DM independent risk factor poor bowel preparation prior colonoscopy Bisacodyl stimulant laxative mi tigate colonic dysmotility associated diabetes We hy pothesized adding bisacodyl splitdose bowel prep aration SDBP improve quality bowel prepara tion patients diabetes Patients methods Adult outpatients aged 18 80 years undergoing colonoscopy recruited One hun dred eightysix patients diabetes randomly assigned 1 3 treatment arms 1 conventional 4 L polyethylene glycol electrolyte lavage solution PEGELS conventional bowel preparation CBP 2 splitdose 4 L PEGELS splitdose bowel preparation SDBP 3 split dose 4 L PEGELS preceded 10 mg oral bisacodyl 10 SDBPB The primary outcome measure bowel cleans ing indicated Boston Bowel Preparation Scale BBPS score Endoscopists blinded preparation Secondary outcome measures safety patient tol erability Results Of 212 patients randomized 186 received assigned bowel preparation There differences study groups regard age indica tion duration DM insulin use narcotic use presence endorgan diabetic complications There trend ward better bowel preparation quality receiv ing SDBP SDBPB compared receiving CBP trend statistically significant 6 BBPS 67 vs 83 vs 75 P 01 In terms safety tolerability differences groups Conclusion Adding bisacodyl SDBP improve quality bowel preparation patients DM Fur ther efforts needed optimize colonoscopy bowel preparation population ClinicalTrialsgov NCT01533688 TRIAL REGISTRATION Interventional Clinical Trial NCT01533688 clinicaltrialsgov d e t b h o r p y l t c r t s s n o t u b r t s d d e z r o h t u n U l y n o e s u l n o s r e p r o f d e d o n w o d l s w t n e m u c o d s h T Introduction Colonoscopy important diagnostic therapeutic proce dure plays critical role diagnosing colonic disorders screening prevention colorectal cancer The effective ness colonoscopy preventing colorectal cancer depends detection removal adenomatous polyps 1 Poor bowel preparation patient intolerance procedure important factors contributing limitations colonoscopy 2 Inadequate bowel cleansing results complete testing increased potential miss lesions increased Madhoun Mohammad F et al Efficacy tolerability Endoscopy International Open 2018 06 E1157E1163 E1157 Original article cost decreased patient satisfaction 3 4 One study evalu ating colonic preparation quality detection neoplasms concluded bowel preparation inadequate 25 patients undergoing colonoscopy 5 Diabetes mellitus DM considered independent risk factor inadequate bowel preparation patients receiving conventional splitdose bowel preparations 6 7 In current study aimed evaluate efficacy tolerability bowel preparation regimens patients diabetes We hypothesized add ing bisacodyl splitdose polyethylene glycol electrolyte la vage solution PEGELS improve bowel cleansing tol erability patients diabetes Patients methods This prospective randomized endoscopistblinded clini cal trial conducted Oklahoma City Veterans Affairs Medi cal Center August 2012 October 2016 The study approved Institutional Review Board IRB Univer sity Oklahoma Health Sciences Center Research Development Office Veterans Affairs Medical Center The study registered ClinicalTrialgov NCT01533688 All authors study access study data viewed approved final manuscript Participants Adult diabetic outpatients referred elective colonoscopy offered informational classroom session going colonoscopy During classroom session patients offered opportunity enroll study If agreed participate informed consent obtained Exclu sion criteria included dietcontrolled DM age younger 18 years known suspected pregnancy known suspected renal failure creatinine clearance 30 unstable angina acute coronary syndrome decompensated congestive heart failure ascites known suspected bowel obstruction major psychia tric illness known allergies PEGELS bisacodyl prior ali mentary tract surgery refusal participate The research pharmacist randomization schedule generated website httpwwwrandomizationcom randomly assign eligible patients bowel preparation regi mens Patients enrolled order scheduled colonoscopy sequence concealed Interventions Participants randomized treatment arms Patients arms received PEGELS Participants ran domized conventional bowel preparation CBP arm instructed ingest preparation 2 4 hours day procedure 1800 hours Patients receiving splitdose PEGELS SDBP ingested 2 L orally 1800 hours day procedure remaining 2 L early morning 3 hours scheduled colonoscopy time Participants SDBPB group received bisacodyl 10 mg orally 1200 hours day prior procedure fol lowed 2 L PEGELS 1800 hours day proce dure 2 L early morning 3 hours scheduled colonoscopy time Participants arms placed clear liquid diet 2 days prior colo noscopy Colonoscopies performed moderate seda tion experienced endoscopists gastroenterology fellow All endoscopists blinded preparation regimen received training occasional reminders Boston Bowel Preparation Score BBPS Data collection After informed consent prior ingesting bowel prep aration participants asked complete survey gastrointestinal symptoms dyspepsia distension bloating diarrhea constipation nausea vomiting abdominal pain severity diabetes duration use insulin history diabetic retinopathy nephropathy peripheral paresthesia history coronary artery disease On day colo noscopy completing bowel preparation patients com pleted questionnaire assess safety tolerability bowel preparation The questionnaire items 1 completion preparation 50 vs 50 2 ease use easy neutral somewhat easy difficult 3 willingness repeat yes vs future needed 4 nau sea vomiting yes vs 5 abdominal bloating yes vs 6 abdominal pain yes vs 7 rectal burning sensation yes vs 8 sleep disturbances yes vs Symptoms ill ness requiring treatment considered severe adverse events Efficacy assessment To measure efficacy bowel preparation Bos ton Bowel Preparation Scale BBPS previously validated bow el preparation scoring based summation preparation scores segments colon right lon transverse colon left colon The total score 9 point scale ranges 0 9 A segment score 0 scribes unprepared colon segment mucosa seen solid stool cleared A seg ment score 1 denotes portion mucosa lon segment seen areas colon seen staining residual stool andor opaque liquid A segment score 2 refers minor residual stain ing small fragments stool andor opaque liquid mucosa colon segment visualized A segment score 3 reflects entire mucosa colon segment visualized residual staining small fragments stool andor opaque liquid The quality bowel preparation graded end procedure endoscopist blinded type preparation based prepara tion prior washing Outcomes The primary outcome adequate bowel preparation quality defined BBPS 6 segmental score 2 subjective rating endoscopist good excellent Secondary outcomes included excellent bowel preparation defined BBPS 7 segmental scores mean BBPS ascending trans E1158 Madhoun Mohammad F et al Efficacy tolerability Endoscopy International Open 2018 06 E1157E1163 d e t b h o r p y l t c r t s s n o t u b r t s d d e z r o h t u n U l y n o e s u l n o s r e p r o f d e d o n w o d l s w t n e m u c o d s h T Randomized n 212 111 randomization Allocated CBP n 71 Allocated SDBPB n 71 Patient canceled n 5 outpatient colonoscopy n 2 medically unstable n 1 Patient canceled n 4 outpatient colonoscopy n 3 medically unstable n 3 Patient canceled n 3 outpatient colonoscopy n 2 medically unstable n 3 Allocated SDBP n 70 Received assigned bowel prep n 63 Received assigned bowel prep n 60 Received assigned bowel prep n 63 Had BBPS score n 56 Had BBPS score n 58 Had BBPS score n 60 BBPS Boston Bowel Preparation Score Fig 1 Flow diagram patients enrolled verse left colon percentage segment score 2 tolerabil ity safety Statistical methods The sample size calculation based comparison prep aration quality score groups We hypothe sized preparation quality SDBPB superior CBP 30 We assumed frequen cy adequate bowel preparation defined BBPS 6 segmental score 2 60 CBP arm 90 SDBPB arm based data previous studies A sample size 62 patients group estimated 80 power twosided alpha 00167 Bonferroni adjusted multiple comparisons We assumed dropout rate 15 Hence total planned number enrollment esti mated 214 patients SAS software SAS Institute Cary North Carolina United States data analyses Con tinuous variables reported means SD Categorical variables reported percentages Twosided ttest compare means continuous variables groups Chisquare test compare categorical variables A P value 00167 considered statistically signifi The intention treat ITT population included ran domized patients met inclusion criteria provided formed consent efficacy bowel prepara tion assessed Results More 600 patients diabetes scheduled patient colonoscopy 2012 2016 Of 212 pa tients agreed participate randomized protocol 71 randomized receive CBP 70 randomized receive SDBP 71 randomized receive SDBPB Of random ized patients 26 complete study receive studyspecified bowel preparations Twelve patients cancel led seven received colonoscopies outside hospital seven medically unstable Fig 1 One eightysix participants underwent colonoscopy included final analysis The groups similar baseline characteristics Fur thermore groups similar baseline medical comorbid ities duration diabetes diabetesrelated complications use insulin medications tricyclic anti depressants group receiv ing SDBP P 003 Table 1 Cecal intubation rate similar groups 6363 100 CBP arm 5960 98 SDBP arm 6363 100 SDBPB arm P 048 One seventyfour participants BBPS docu mentation The 12 participants BBPS docu mentation objective assessments quality bowel preparations Madhoun Mohammad F et al Efficacy tolerability Endoscopy International Open 2018 06 E1157E1163 E1159 d e t b h o r p y l t c r t s s n o t u b r t s d d e z r o h t u n U l y n o e s u l n o s r e p r o f d e d o n w o d l s w t n e m u c o d s h T Original article Table 1 Baseline characteristics Age mean SD Male sex n White race n Indication FIT positive n DM Duration 5 yr n Insulin use n HgbA1c mean SD Diabetic retinopathy n Diabetic nephropathy n Diabetic neuropathy n History CAD n Cirrhosis n Stroke n Dementia n Narcotics use n CCB n TCA n CBP n 63 647 64 61 968 41 651 52825 23 365 23 365 73 14 7 111 2 32 38 603 17 269 1 16 3 48 0 0 21 333 19 301 3 48 SDBP n 60 628 72 59 983 45 75 44733 26 433 21 35 74 18 7 117 2 33 39 65 23 383 4 67 4 67 1 17 18 30 22 367 10 167 SDBPB n 63 632 67 58 921 51 809 48 762 24 381 24 381 74 16 6 95 3 48 41 651 23 365 4 64 6 95 1 16 24 381 23 365 3 48 P value 025 019 014 046 072 094 087 092 087 081 036 033 057 059 063 068 003 CBP conventional bowel preparation SDBP splitdose bowel preparation SDBPB splitdose bowel preparation plus bisacodyl FIT fecal immunochemical test DM diabetes mellitus CCB calcium channel blocker TCA tricyclic antidepressant SD standard deviation Primary secondary outcomes Most participants achieved adequate bowel preparation total BBPS score 6 segment scores 2 4263 667 CBP arm 5060 833 SDBP arm 4763 746 SDPB arm P 010 Including 12 patients BBPS scores subjective rat ing bowel preparation showed comparable results 762 CBP 85 SDBP 778 SDPB P 064 The mean BBPS 67 15 participants CBP arm compared 73 16 patients SDBP arm 71 14 participants SDBPB arm P 026 Table 2 Data colon segment analyzed More patients CBP arm 1456 25 BBPS scores 2 right patients SDBP arm 558 103 SDBPB arm 960 15 This difference neared statistical sig nificance P 002 Similarly mean rightside segmental BBPS score significantly lower patients CBP arm 19 06 patients SDBP 23 06 SDBPB 21 06 arms P 0003 Table 2 Safety tolerability Most participants treatment arms completed 50 assigned bowel preparation About twothirds partici pants felt preparation easy neutral Inci dence treatmentrelated effects similar groups There trend willingness peat procedure SDBP 90 SDBPB 92 CBP 84 loss sleep SDBP 50 SDBPB 54 CBP 44 splitdose groups relative CBP group Table 3 There adverse events One patient SDBP group presented morning procedure newonset atrial fibrillation felt unrelated bowel preparation Discussion In randomized controlled trial RCT adding bisacodyl SDBP improve quality bowel preparation pa tients DM To knowledge RCT evalu ate bowel preparation patients DM Gastrointestinal symptoms common patients DM general population 8 The common gastrointestinal complaint constipation occurring 60 patients 9 Prolonged gut colonic transient times observed 40 patients diabetes 9 Gastroparesis common 8 Delayed gastric emptying demonstrated 27 65 patients type I DM approximately 30 patients type II DM 10 Need colonoscopy common patients DM given high prevalence gastrointestinal symptoms possi ble increased risk colon cancer 11 12 Previous studies sug E1160 Madhoun Mohammad F et al Efficacy tolerability Endoscopy International Open 2018 06 E1157E1163 d e t b h o r p y l t c r t s s n o t u b r t s d d e z r o h t u n U l y n o e s u l n o s r e p r o f d e d o n w o d l s w t n e m u c o d s h T Table 2 Quality bowel preparation Aggregate Score BBPS 6 n 1 BBPS 7 n 1 Adequate n Overall BBPS mean SD Segment score2 CBP n 63 42 667 31 492 48 762 67 15 SDBP n 60 50 833 37 617 51 85 73 16 SDBPB n 63 47 746 38 603 49 778 71 14 Right BBPS 2 n 1456 25 558 103 960 15 Transverse BBPS 2 n Left BBPS 2 n Right mean SD Transverse mean SD Left mean SD 456 71 356 54 19 06 24 06 24 06 158 35 358 52 23 06 26 06 25 06 3 5 160 17 21 06 24 06 26 05 P value 010 030 064 013 002 049 076 0003 018 048 CBP conventional bowel preparation SDBP splitdose bowel preparation SDBPB splitdose bowel preparation plus bisacodyl BBPS Boston bowel preparation score SD standard deviation 1 Calculation based patients available BBPS 2 Calculation based patients available BBPS Table 3 Safety tolerability Completed 50 Found easy neutral Nauseavomiting Bloating Abdominal pain Rectal burning sensation Loss sleep CBP n 61 989 45 723 6 97 10 161 2 32 6 97 27 436 Willingness repeat bowel preparation 52 839 SDBP n 56 983 43 754 4 69 10 172 4 69 9 156 29 50 52 897 SDBPB n 63 100 50 795 6 95 10 159 2 32 10 159 34 539 58 921 P value 058 067 085 097 051 052 051 030 CBP conventional bowel preparation SDBP splitdose bowel preparation SDBPB splitdose bowel preparation plus bisacodyl SD standard deviation gested rate inadequate bowel preparation ranged 20 38 patients diabetes 13 16 Few studies explored ways improve bowel prepara tion group patients Three studies examined alterna tive strategies improve quality bowel preparation pa tients DM conventional singledose PEGELS inges ted night procedure One study 6 L PEG ELS rate inadequate bowel preparation 38 13 In study investigators lubipros tone adjunct single dose 4 L PEGELS An improve ment 24 good excellent bowel preparation 47 observed difference statistically significant 17 Finally Hayes et al explored option adding ses magnesium citrate usual singledose PEGELS A statistically significant improvement good bowel preparation reported 54 vs 70 18 The rate inadequate bowel preparation noticeably high studies higher rate inadequate bowel preparation observed conventional group current study 25 This study different required clear liquid diet 2 days patients attended educational class prior colonos copy These differences explain lower rate inade quate bowel preparation conventional arm observed Splitdose PEGELS shown effective strategy improving bowel preparation current guide Madhoun Mohammad F et al Efficacy tolerability Endoscopy International Open 2018 06 E1157E1163 E1161 d e t b h o r p y l t c r t s s n o t u b r t s d d e z r o h t u n U l y n o e s u l n o s r e p r o f d e d o n w o d l s w t n e m u c o d s h T Original article lines recommend use patients 19 While study demonstrate difference adequate bowel preparation patients receiving SDBP compared CBP im provement right colon scores There lim ited evidence suggest regimen improves bowel prepara tion patients DM One recently published study exam ined effect multifactorial strategy combining educa tional intervention 4 days lowfiber diet adjustment blood glucoselowering agents quality bowel prepara tion patients DM receiving splitdose bowel prepa ration The researchers multifactorial strategy resulted adequate bowel preparation compared conventional protocol lowfiber diet 4 days clear li quid diet day procedure 93 vs 80 P 0014 15 Similarly 82 patients splitdose groups achieved adequate bowel preparation compar able rate adequate bowel preparation Alvarez Gonzalez studys standard splitdose treatment arm 80 These results clearly demonstrate inadequate bowel prep aration common diabetic patients despite following current guidelines 19 The current guidelines recommend liquid diet patients high risk inadequate lon preparation e g patients DM 19 Concerns hypoglycemia theoretically lead adherence laxative intake possibility impair ment motility function raised In study pub lished AlvarezGonzalez duration clear liquid diet 8 hours multifactorial strategy group compared 24 hours standard care group In current study patients asked follow clear liquid diet 2 days colonoscopy The duration clear liquid diet likely plays role quality bowel preparation patients DM It possible time clear liquid diet results better bowel preparation merits investi gation unclear prolonged diet clear liquids impacted results The mechanism motility dysfunction patients DM unclear It suggested dysfunction autonomic neuropathy gastrointestinal tract 20 hyperglycemia 21 Studies shown lonic smooth muscle stimulated patients DM 20 Bisacodyl prokinetic hydragogue effect acts locally large bowel directly enhancing motility reducing transit time 22 Our study im provement bowel preparation patients received bisacodyl splitdose bowel preparation suggests motility dysfunction complex im proved stimulant laxative Studies suggested splitdose PEGELS enhances patients compliance tolerability preparation creasing time required consume entire volume la vage solution In metaanalysis RCTs adult patients com paring effect splitdose PEGELS conventional dose PEGELS splitdose PEGELS resulted reduced nausea im proved bowel preparation improved patient compliance increased willingness repeat preparation 23 In current study observe statistically significant difference splitdose groups conventional group regard tolerability However consistent trials numerical trend willingness peat procedure loss sleep observed There limitations study The study ducted VA medical center patient population majority patients male white Thus results generalizable general population In addi tion recommended BBPS documented endoscopist performed colon washing In cur rent study required documentation bowel prepara tion score prior washing assess impact bow el preparation intraprocedural time spent wash ing While endoscopists reminded protocol BPPS documentation possible end procedure scor ing replicates clinical practice impaired scor ing accuracy The high rate CBP adequate preparation com pared trials limited power detect difference Conclusion In conclusion adding bisacodyl SDBP improve quality bowel preparation diabetic patients Further ef forts needed optimize bowel preparation popula tion Acknowledgements Grant support provided South Central VA Healthcare Network SCVAHCN Competing interests None References 1 Winawer SJ Zauber AG Ho MN The National Polyp Study Workgroup et al Prevention colorectal cancer colonoscopic polypectomy N Engl J Med 1993 329 1977 1981 2 Kim WH Cho YJ Park JY et al Factors affecting insertion time patient discomfort colonoscopy Gastrointest Endosc 2000 52 600 605 3 Ness RM Manam R Hoen H et al Predictors inadequate bowel preparation colonoscopy Am J Gastroenterol 2001 96 1797 1802 4 Rex DK Imperiale TF Latinovich DR et al Impact bowel preparation efficiency cost colonoscopy Am J Gastroenterol 2002 97 1696 1700 5 Harewood GC Sharma VK Garmo P Impact colonoscopy prep aration quality detection suspected colonic neoplasia Gastro intest Endosc 2003 58 76 79 6 Fayad NF Kahi CJ Abd ElJawad KH et al Association body mass index quality split bowel preparation Clin Gstroenterolo Hepatol 2013 11 1478 1485 E1162 Madhoun Mohammad F et al Efficacy tolerability Endoscopy International Open 2018 06 E1157E1163 d e t b h o r p y l t c r t s s n o t u b r t s d d e z r o h t u n U l y n o e s u l n o s r e p r o f d e d o n w o d l s w t n e m u c o d s h T 7 Dik VK Moons LM Huyuk M et al Predicting inadequate bowel prep aration colonoscopy participants receiving splitdose bowel preparation development validation prediction score Gas trointest Endosc 2015 81 665 672 8 Bytzer P Talley NJ Leemon M et al Prevalence gastrointestinal symptoms associated diabetes mellitus populationbased sur vey 15000 adults Arch Intern Med 2001 161 1989 1996 9 Feldman M Schiller LR Disorders gastrointestinal motility asso ciated diabetes mellitus Ann Intern Med 1983 98 378 384 10 Parkman HP Yates K Hasler WL et al Similarities differences tween diabetic idiopathic gastroparesis Clin Gastroenterol He patol 2011 9 1056 1064 quiz e133134 16 Madhoun MF Bitar H Bhatti O et al Diabetics narcotics likely achieve excellent bowel preparation patients condition Dig Dis Sci 2017 62 723 729 17 Grigg E Schubert MC Hall J et al Lubiprostone polyethy lene glycol diabetic patients enhances colonoscopy preparation quality World J Gstrointest Endosc 2010 2 263 267 18 Hayes A Buffum M Hughes J Diabetic colon preparation comparison study Gastroenterol Nurs 2011 34 377 82 19 Johnson DA Barkun AN Cohen LB et al Optimizing adequacy bowel cleansing colonoscopy recommendations US MultiSociety Task Force Colorectal Cancer Am J Gastroenterol 2014 109 1528 1545 11 La VecchiaC Negri E Decarli A et al Diabetes mellitus colorectal cancer risk Cancer Epidemiol Biomarkers Prev 1997 6 1007 1010 20 Battle WM Snape WJ Jr Alavi A et al Colonic dysfunction diabetes mellitus Gastroenterology 1980 79 1217 1221 12 Will JC Galuska DA Vinicor F et al Colorectal cancer com plication diabetes mellitus Am J Epidemiol 1998 147 816 825 13 Taylor C Schubert ML Decreased efficacy polyethylene glycol la vage solution golytely preparation diabetic patients outpatient colonoscopy prospective blinded study Am J Gas troenterol 2001 96 710 714 14 Ozturk NA Gokturk HS Demir M et al Efficacy safety sodium phosphate colon cleansing type 2 diabetes mellitus South Med J 2010 103 1097 1102 15 AlvarezGonzalez MA FloresLe Roux JA Seoane A et al Efficacy multifactorial strategy bowel preparation diabetic patients dergoing colonoscopy randomized trial Endoscopy 2016 48 1003 1009 21 Sims MA Hasler WL Chey WD et al Hyperglycemia inhibits mechan oreceptormediated gastrocolonic responses colonic peristaltic reflexes healthy humans Gastroenterology 1995 108 350 359 22 Herve S Savoye G Behbahani A et al Results 24h manometric cording colonic motor activity endoluminal instillation bi sacodyl patients severe chronic slow transit constipation Neurogastroenterol Motil 2004 16 397 402 23 Kilgore TW Abdinoor AA Szary NM et al Bowel preparation splitdose polyethylene glycol colonoscopy metaanalysis randomized controlled trials Gastrointest Endosc 2011 73 1240 1245 d e t b h o r p y l t c r t s s n o t u b r t s d d e z r o h t u n U l y n o e s u l n o s r e p r o f d e d o n w o d l s w t n e m u c o d s h T Madhoun Mohammad F et al Efficacy tolerability Endoscopy International Open 2018 06 E1157E1163 E1163